COGT - Company ID 0001622229
Cogent Biosciences, Inc. has filed 593 public company documents between 2014 and 2026. The most frequent type is insider trade (207 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| SCHEDULE 13D/A | SCHEDULE 13D/A | 3mo ago2026-03-31 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 5mo ago2026-01-22 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 7mo ago2025-11-17 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 12mo ago2025-07-14 | - | View filing |